Why Science? | sc-GEM, Targeted Genotype, DNA-Methylation and Gene-Expression Evidence

Section 1 of 36

1. Start with a targeted three-part question

sc-GEM asks whether selected DNA variants, transcripts and methylation-sensitive sites coexist in one cell. Because the targets are chosen before the experiment, the method is excellent for testing focused biological models. It is not an untargeted whole-genome, whole-transcriptome or complete methylome survey.

Contents · Next section

Section 2 of 36

2. Did you know one chip can coordinate three assays?

The foundational study used an automated Fluidigm microfluidic platform to capture and process single cells. Miniaturisation supports parallel reactions and preserves a shared cell address. It also introduces capture-size, loading, fluidic and recovery filters that should appear in the evidence record.

Contents · Previous section · Next section

Section 3 of 36

3. Define genotype evidence

Genotype calls come from amplified selected genomic loci and next-generation sequencing. A detected allele can help distinguish tumour or cell populations. Allelic dropout, amplification imbalance and sequencing error can hide or distort heterozygous states, so controls and replicate loci matter.

Contents · Previous section · Next section

Section 4 of 36

4. Define expression evidence

Reverse-transcribed RNA is measured with targeted qPCR assays. Cycle-threshold values reflect amplification of selected transcripts within a validated dynamic range. A non-detect can mean very little RNA, inefficient reverse transcription or failed amplification; it should not automatically be labelled biological absence.

Contents · Previous section · Next section

Section 5 of 36

5. Define methylation evidence

sc-GEM uses methylation-sensitive restriction digestion at selected CCGG-containing loci. Protection from digestion can support methylation, while cutting can support an unmethylated state under the assay conditions. Restriction-site availability, digestion efficiency and primer performance limit which methylation questions can be asked.

Contents · Previous section · Next section

Section 6 of 36

6. Keep the panel boundary visible

A carefully selected panel can be more sensitive and interpretable than a shallow global assay. Yet unmeasured genes, variants and CpGs remain unknown. Conclusions should say which loci were tested and avoid describing a panel result as the molecular state of an entire cell.

Contents · Previous section · Next section

Section 7 of 36

7. Design the biological contrast first

Choose cell populations, expected variants, expression markers, methylation targets, controls and primary comparisons before programming the chip. Independent donors, tumours or cultures define biological replication. Ninety-six wells from one specimen provide cell diversity, not ninety-six independent people.

Contents · Previous section · Next section

Section 8 of 36

8. Capture one cell with provenance

Record the source specimen, suspension quality, loading conditions, capture site and image where available. Empty chambers, doublets and damaged cells belong in the recovery funnel. A reliable single-cell conclusion begins with evidence that the reaction really started from one suitable cell.

Contents · Previous section · Next section

Section 9 of 36

9. Reverse-transcribe RNA before DNA digestion

RNA is converted to cDNA so transcript signals can later be amplified. The genomic DNA remains available for restriction analysis and genotyping. Timing, enzyme performance and inhibitors can affect channels differently; a strong genotype result does not prove that the RNA channel worked.

Contents · Previous section · Next section

Section 10 of 36

10. Apply methylation-sensitive restriction carefully

The restriction enzyme should cut its recognition sequence when the relevant cytosines are not protected by methylation. Include digest-positive, digest-negative and no-enzyme controls. Incomplete digestion can imitate methylation, making enzyme performance part of the result rather than a hidden technical detail.

Contents · Previous section · Next section

Section 11 of 36

11. Amplify selected DNA and cDNA targets

Multiplex PCR produces material for genotype sequencing, expression qPCR and methylation calls. Primer competition, target abundance and cycle number can reshape relative recovery. Validate each assay alone and in the multiplex, then freeze the panel before comparing biological groups.

Contents · Previous section · Next section

Section 12 of 36

12. Attach barcodes without losing cell identity

Sequencing adapters associate genotype amplicons with the original cell. The qPCR outputs must join the same address exactly. Preserve a machine-readable plate map and test for duplicate or missing identifiers. A clean-looking multimodal profile can be false if one join shifts by a well.

Contents · Previous section · Next section

Section 13 of 36

13. Calibrate single-copy sensitivity

The primary report assessed amplification at loci expected to be present in single copy per haploid genome and reported high amplification success under its conditions. That demonstrates feasibility for validated targets. Every new panel still needs its own limit-of-detection, specificity and dropout study.

Contents · Previous section · Next section

Section 14 of 36

14. Use standards for expression range

Bulk RNA standards and single-cell distributions can show whether qPCR measurements sit inside a usable range. Report efficiency, negative controls and how undetermined values are handled. Compressing every late cycle into a numeric expression value can manufacture fine differences where evidence is weak.

Contents · Previous section · Next section

Section 15 of 36

15. Practise with a fictional targeted panel

These invented values teach review logic, not sc-GEM performance.

Contents · Previous section · Next section

Section 16 of 36

16. Read the reprogramming experiment as a trajectory sample

The study profiled fibroblasts undergoing reprogramming and compared selected somatic and pluripotency-related markers. Cells collected at different stages are snapshots, not the same cell followed through time. A smooth ordering is a model that needs time, controls and independent cultures.

Contents · Previous section · Next section

Section 17 of 36

17. Read the lung-tumour application as heterogeneity evidence

Primary lung adenocarcinoma samples showed that targeted genotype and transcriptional information could identify cellular groups whose methylation patterns differed. This supports subtype-aware epigenetic analysis within the sampled tumours. It does not establish prevalence, prognosis or treatment response.

Contents · Previous section · Next section

Section 18 of 36

18. Separate cell identity from methylation interpretation

Genotype and expression markers can help define which cells should be compared. Only then should methylation differences be interpreted. If identity is uncertain, an apparent epigenetic subgroup may instead reflect mixed lineages, doublets or marker dropout.

Contents · Previous section · Next section

Section 19 of 36

19. Model donors rather than treating cells as people

Cells share specimen history, genetics, collection and processing. Population claims should use donor- or tumour-aware summaries and uncertainty. Thousands of measurements from one tumour can describe that tumour precisely while saying little about how often the pattern occurs in patients.

Contents · Previous section · Next section

Section 20 of 36

20. Show the three quality funnels

Report cells attempted, valid singlets, genotype-pass, expression-pass, methylation-pass and the three-way intersection. Stratify by chip, specimen and group. Joint filtering can preferentially remove a biological state, so retained and excluded cells should be compared with available independent information.

Contents · Previous section · Next section

Section 21 of 36

21. Interpret co-variation without inventing causality

A variant, transcript and methylation state can co-occur because one influences another, because they mark a shared lineage or because a third process affects all three. Same-cell measurement sharpens the association. Perturbation and broader functional evidence are needed for mechanism.

Contents · Previous section · Next section

Section 22 of 36

22. Challenge allelic dropout

A heterozygous cell can appear homozygous when one allele fails to amplify. Estimate dropout with known heterozygous controls, multiple loci and repeated reactions. Rare genotypes supported by a single amplicon deserve cautious wording and independent confirmation.

Contents · Previous section · Next section

Section 23 of 36

23. Challenge incomplete digestion

Residual undigested DNA can be called methylated even when the site was unmethylated. Monitor enzyme controls by chip and target, set prespecified acceptance rules and repeat conclusions under stricter digestion thresholds. A batch-wide shift is chemistry until evidence supports biology.

Contents · Previous section · Next section

Section 24 of 36

24. Challenge primer-panel bias

Targets with efficient primers dominate multiplex reactions, while weak assays may fail selectively. Report primer sequences, efficiencies and competition tests. A missing signal outside the validated operating range is an assay limitation, not evidence that a cell lacks the molecule.

Contents · Previous section · Next section

Section 25 of 36

25. Challenge microfluidic selection

Large, fragile or adherent cells may load differently from robust cells. Compare input material with recovered cells using size, viability, pathology or independent markers. Observed cell proportions describe specimen plus device; they are not automatically an unbiased census.

Contents · Previous section · Next section

Section 26 of 36

26. Challenge rare-population excitement

A small cluster can be biologically important, but it is also vulnerable to doublets, contamination, index errors and threshold choices. Inspect the original wells, genotype coherence, expression markers, digestion controls and recurrence across specimens before elevating it to a new subtype.

Contents · Previous section · Next section

Section 27 of 36

27. Validate the weakest inference

Confirm genotype with an orthogonal DNA assay, expression with targeted RNA methods, and methylation with bisulfite or another locus-specific approach. If the claim is that methylation changes expression, perturb the regulatory system rather than merely repeating the same correlation.

Contents · Previous section · Next section

Section 28 of 36

28. Build Primary Science fair-test habits

Children can model three colour-coded observations from one bead and ask which result changed after one controlled treatment. The activity teaches labelling, fair comparison and the difference between observation and explanation without requiring advanced molecular vocabulary.

Contents · Previous section · Next section

Section 29 of 36

29. Prepare for PSLE Science data questions

A small targeted table lets pupils identify a failed control, compare only valid rows and suggest a repeat. They learn that more columns do not rescue unreliable measurements and that a conclusion must match the tested variables.

Contents · Previous section · Next section

Section 30 of 36

30. Deepen Secondary Science reasoning

Students can trace DNA, RNA, enzymes, restriction sites, PCR and sequencing through the workflow. Each step offers controlled variables and failure modes. The panel also demonstrates how researchers trade breadth for sensitivity and interpretability.

Contents · Previous section · Next section

Section 31 of 36

31. Connect to O-Level Science

The official 2026 Biology and Chemistry syllabuses emphasise planning, analysis and evaluation. sc-GEM provides a modern context for enzymes, nucleic acids, chemical specificity, controls and evidence. The educational goal is reasoned evaluation, not memorising an acronym.

Contents · Previous section · Next section

Section 32 of 36

32. Make school choices with verified questions

Families can ask how schools support practical work, quantitative thinking, computing, communication and wellbeing, then verify current programmes on official pages. One exciting genomics method cannot rank schools, establish admissions rules or guarantee a career.

Contents · Previous section · Next section

Section 33 of 36

33. See careers behind the chip

The work connects molecular biologists, microfluidics engineers, laboratory technologists, cancer researchers, computational analysts, statisticians, quality specialists, ethics teams and data stewards. Multiple education pathways can lead toward these roles, followed by specialised training.

Contents · Previous section · Next section

Section 34 of 36

34. Use science tuition for precise conclusions

Tuition can help learners practise variables, enzyme reasoning, tables and cautious writing. A good lesson asks what an undigested control means, why one tumour is not a population and which assay validates a genotype. It does not promise grades or admission.

Contents · Previous section · Next section

Section 35 of 36

35. Did you know targeted can be a strength?

Global profiling is not always the best first tool. A validated targeted panel can test a specific hypothesis deeply across many cells and link known markers within the same cell. Its scientific honesty depends on stating exactly what was outside the panel.

Contents · Previous section · Next section

Section 36 of 36

36. Finish with a panel-aware robustness map

Vary genotype quality, expression thresholds, digestion acceptance, doublet rules, cell identities and specimen inclusion. Mark which subgroup and cross-layer patterns persist. Robust targeted evidence earns stronger wording; unstable results become focused hypotheses for a redesigned panel or broader assay.

A publication-ready sc-GEM project should archive a target ledger as carefully as its cell matrix. For every genotype, transcript and methylation target, record the biological reason for inclusion, genome build, primer sequence, restriction site, expected product, amplification efficiency, dynamic range, specificity and failure rule. Freeze the panel before group comparison. This record makes clear that an unmeasured locus was outside scope and prevents a post-hoc target choice from masquerading as a prespecified hypothesis.

The recovery funnel should begin with input cells and end with the joint set. Show chip chambers loaded, apparent singlets, successful reverse transcription, genotype-pass reactions, expression-pass reactions, digest-controlled methylation calls and three-way accepted cells for every independent specimen. Overlay cell size, viability and imaging when available. If a tumour subgroup is more likely to fail capture or one assay, its representation in the final table may be biased even when every retained row is technically valid.

Restriction controls deserve their own figure. Include no-enzyme material, known digestible unmethylated DNA and methylated or protected controls for each target and batch. Report residual uncut signal and the threshold that defines a call. Because incomplete cutting imitates methylation, a plate-wide increase should remain a chemistry concern until controls and an orthogonal assay support biology. Repeat key conclusions under stricter thresholds and with ambiguous calls retained rather than forced into two states.

Expression analysis should preserve raw cycle-threshold information, amplification efficiency and undetermined reactions. Standards can establish a usable range, but the relationship between cycle number and starting molecules depends on efficiency. Avoid ranking tiny differences near the detection limit as precise biological gradients. A sensitivity analysis can treat late values as censored, missing or low and show whether the cell grouping survives.

Tumour conclusions need patient-aware language. A rare cell population supported by genotype, expression and methylation may reveal within-specimen heterogeneity, yet clinical prevalence and relevance require independent patients, pathology and prospective validation. Show each specimen separately before pooling. A pattern recurring across several tumours earns broader interest; a one-tumour pattern remains a transparent case observation and a strong candidate for follow-up.

Figures should move from target rationale and chip capture through three quality funnels, single-modality views, the accepted joint set and orthogonal validation. Label measured, normalised, thresholded and inferred values. Preserve plate and specimen colours beneath biological labels. Readers should be able to trace a striking cell back to its chamber, controls and individual assay results.

Reproducibility covers specimen provenance, cell preparation, chip model and settings, microscopy, reverse transcription, restriction digestion, primers, multiplex PCR, qPCR, sequencing, barcodes, genotype calling, threshold rules, cell joins, statistics, code and software versions. Human genomic and tumour data need proportionate consent, access and governance. Biological samples, enzymes, amplified DNA and chemicals require trained institutional practice.

The educational message is optimistic: advanced science still rests on familiar habits. Label samples, control one variable, record failed trials, compare like with like and match the conclusion to the tested panel. Those habits strengthen Primary Science observations, PSLE Science tables, Secondary Science practicals and professional research. sc-GEM is memorable because a focused set of well-controlled questions can reveal hidden cellular diversity without pretending to measure everything.

Before publication, build a claim register that pairs every sentence-level conclusion with its exact targets, accepted cells, independent specimens, effect size, uncertainty and validating evidence. Include a column for what the panel could not observe. Test whether subgroup labels survive the removal of one marker at a time and whether methylation differences remain when genotype and expression classifications are held fixed. This prevents a circular analysis in which the same target both defines a subgroup and is then presented as independent proof of that subgroup. Archive the register, raw plate map and analysis code together so another team can reproduce not only the numbers but also the reasoning path.

Finally, distinguish discovery from future use. A compact sc-GEM panel may become attractive for screening many cells after broader work identifies relevant loci, but each new application needs fresh analytical validation, specimen-appropriate controls and, for clinical use, regulated performance studies. Targeted efficiency is valuable precisely because it narrows the question. Keeping that narrowness visible protects readers from overreach and helps the next experiment choose whether to refine the panel, add orthogonal assays or return to an untargeted discovery method.

Contents · Previous section · Continue to the Science Learning Hub